Assessment of CCR5/maraviroc immunotherapy in combination with PD1 and MR-guided radiotherapy for treatment of pancreatic cancer.

Hughes S., Lanfredini S., Thappa A., Mukherjee S., O'Neill E.

Type

Conference paper

Publication Date

03/2020

Volume

8

Pages

120 - 120

Permalink